SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-23-035848
Filing Date
2023-02-13
Accepted
2023-02-13 16:16:55
Documents
1
Group Members
JOSHUA BARER

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d428779dsc13ga.htm SC 13G/A 56061
  Complete submission text file 0001193125-23-035848.txt   57583
Mailing Address 9119 GAITHER ROAD GAITHERSBURG MD 20878
Business Address 9119 GAITHER ROAD GAITHERSBURG MD 20878 301-825-9810
NexImmune, Inc. (Subject) CIK: 0001538210 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92432 | Film No.: 23618714
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NEXIMMUNE, INC. 9119 GAITHER ROAD GAITHERSBURG MD 20877
Business Address C/O NEXIMMUNE, INC. 9119 GAITHER ROAD GAITHERSBURG MD 20877 301-825-9810
B&S NexImmune Holdco LLC (Filed by) CIK: 0001844967 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A